Evidence map›Paper›PMID 36110975›Full record

ArticleContrast media & molecular imaging2022

Regulation of Quality of Life and Immune Function in Patients with Thyroid Cancer Treated by Deep Learning Technology.

Xiandong Fu, Xinxin Yang, Yibo Wang, Nannan Chi, Jianan Yu, Yao Feng

RetractedAbstract readRetracted Publication
In one paragraph

Article in Contrast media & molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Xiandong FuDepartment of General Surgery, the First Affiliated Hospital of Jiamusi University, Jiamusi 154000, Heilongjiang, China.
Xinxin YangDepartment of General Surgery, the First Affiliated Hospital of Jiamusi University, Jiamusi 154000, Heilongjiang, China.
Yibo WangSchool of Clinical Medicine, Jiamusi University, Jiamusi 154000, Heilongjiang, China.
Nannan ChiDigestive Department, the First Affiliated Hospital of Jiamusi University, Jiamusi 154000, Heilongjiang, China.ORCID 0000-0003-1006-6751
Jianan YuDepartment of Neurology, the First Affiliated Hospital of Jiamusi University, Jiamusi 154000, Heilongjiang, China.
Yao FengTraditional Chinese Medicine Department, the First Affiliated Hospital of Jiamusi University, Jiamusi 154000, Heilongjiang, China.ORCID 0000-0002-4300-8091

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In order to explore the regulation of quality of life and immune function in patients with thyroid cancer after radiotherapy, a method based on deep learning technology was proposed. A deep learning detection method for thyroid cancer is proposed. Methods: It mainly includes three main modules: data preprocessing, thyroid cancer regional detection module, and thyroid cancer benign and malignant classification module. The data set in the experiment comes from LIDC-IDRI and is processed by the data preprocessing module to generate a standard data format that can be processed by the framework. The treatment of thyroid cancer can help patients relapse malignant thyroid cancer and prevent recurrence in advance. Results: The results showed that most patients are diagnosed because of obvious swelling of local thyroid mass and conscious compression symptoms in the neck. At this time, they often miss the best treatment time, so as to reduce the surgical effect. Conclusions: The metastasis and invasion of cancer cells are fast, the cancerous lesions are easy to form adhesion with the surrounding tracheal tissue, and the cancer cells invade the surrounding soft tissue, which is also easy to cause the cancerous tissue not to be completely removed.

Indexed as

Deep LearningThyroid NeoplasmsHumansImmunityNeoplasm Recurrence, LocalQuality of LifeTechnology

Identifiers

PMID36110975
PMCPMC9448623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.